Schedule 13G ownership disclosure
SOLENO THERAPEUTICS INC
Security class unavailable · CUSIP: 834203200
Event date: 2017-12-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,180,463
- Percent of class
- 6.1660%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-065356
- Form type
- SC 13G
- Filer
- Birchview Capital, LP
- CIK
- CIK 1618205
- Filed
- Dec 26, 2017
- Reporting period
- Dec 15, 2017
- Description
- Schedule 13G beneficial ownership